| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1013.json | Diagnostic Studies During Pregnancy | active | | | 2022-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1019.json | Pregnancy Test | active | | | 2023-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1022.json | Complications of Pregnancy, Childbirth and the Puerperium | active | | | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1023.json | Complications of Pregnancy, Childbirth and the Puerperium | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1028.json | Procedures for Sexual Activity | active | | | 2024-02 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1030.json | Procedures for Sexual Activity | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1031.json | Diagnosis for Sexual Activity | active | | | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1032.json | Diagnosis for Sexual Activity | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.11.1033.json | Procedures for Sexual Activity | active | | | 2021-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.12.1007.json | Lab Tests During Pregnancy | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.12.1008.json | Diagnostic Studies During Pregnancy | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.12.1011.json | Pregnancy Test | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.12.1012.json | Complications of Pregnancy, Childbirth and the Puerperium | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.12.1016.json | Congenital or Acquired Absence of Cervix | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.12.1017.json | Procedures Used to Indicate Sexual Activity | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.111.12.1018.json | Diagnoses Used to Indicate Sexual Activity | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.112.11.1024.json | Absence of Cervix | active | | | 2021-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.112.11.1025.json | Absence of Cervix | active | | | 2021-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.112.11.1026.json | Absence of Cervix | active | | | 2023-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1073.json | Osteoporosis Without Current Fracture | active | | | 2017-12 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1074.json | Osteoporosis Without Current Fracture | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1200.json | Osteoporosis With Current Fracture | active | | | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1201.json | Osteoporosis With Current Fracture | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1202.json | DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine | active | | | 2021-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1308.json | Frailty Diagnosis | active | | | 2024-11 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1309.json | Frailty Diagnosis | active | | | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1310.json | Frailty Symptom | active | | | 2023-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.11.1311.json | Frailty Symptom | active | | | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.12.1038.json | Osteoporosis Without Current Fracture | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.12.1050.json | Osteoporosis With Current Fracture | active | | | 2018-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.12.1051.json | DXA (Dual energy Xray Absorptiometry) Scan | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.12.1074.json | Frailty Diagnosis | active | | | 2019-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.113.12.1075.json | Frailty Symptom | active | | | 2019-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.114.11.1021.json | Narcolepsy | active | | | 2018-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.114.11.1023.json | Narcolepsy | active | | | 2017-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.114.11.1024.json | Neurologic impairment | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.114.11.1025.json | Neurologic impairment | active | | | 2017-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.114.11.1026.json | Neurologic impairment | active | | | 2021-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.114.12.1011.json | Narcolepsy | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.114.12.1012.json | Neurologic impairment | active | | | 2024-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1149.json | Substance Use Disorder Long Acting Medication | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.115.11.1248.json | Retinal or Dilated Eye Exam | active | | | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.115.12.1088.json | Retinal or Dilated Eye Exam | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1150.json | Substance Use Disorder Short Acting Medication | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1151.json | Substance Use Disorder Long Acting Medication Administration | active | | | 2025-01 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1152.json | Substance Use Disorder Short Acting Medication Administration | active | | | 2024-02 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1155.json | Substance Use Disorder Short Acting Medication Administration | active | | | 2023-11 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1156.json | Substance Use Disorder Long Acting Medication Administration | active | | | 2021-11 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1157.json | Substance Use Disorder Short Acting Medication Administration | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1163.json | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine | active | | | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1164.json | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine | active | | | 2022-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1165.json | Hospice Diagnosis | active | | | 2022-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1166.json | Hospice Diagnosis | active | | | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1167.json | Palliative Care Diagnosis | active | | | 2022-08 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1168.json | Palliative Care Diagnosis | active | | | 2022-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1169.json | Palliative Care Diagnosis | active | | | 2022-08 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.117.11.1031.json | Hyperthyroidism | active | | | 2018-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.117.11.1033.json | Hyperthyroidism | active | | | 2018-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.117.11.1034.json | Hyperparathyroidism | active | | | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.117.11.1036.json | Hyperparathyroidism | active | | | 2018-03 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.117.12.1015.json | Hyperthyroidism | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.117.12.1016.json | Hyperparathyroidism | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1170.json | Atomoxetine | active | | | 2022-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1171.json | Clonidine | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1172.json | Dexmethylphenidate | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1173.json | Dextroamphetamine | active | | | 2022-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1174.json | Lisdexamfetamine | active | | | 2022-09 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1176.json | Methylphenidate | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1177.json | Lower Body Fractures Excluding Ankle and Foot | active | | | 2022-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1178.json | Lower Body Fractures Excluding Ankle and Foot | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1179.json | Malignant Neoplasms of Lower and Unspecified Limbs | active | | | 2022-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.118.11.1042.json | Counseling for Physical Activity | active | | | 2019-03 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.118.11.1077.json | Falls Screening | active | | | 2018-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.118.11.1097.json | CT Colonography | active | | | 2019-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.118.11.1220.json | Frailty Device SNOMED | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.118.12.1028.json | Falls Screening | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.118.12.1035.json | Counseling for Physical Activity | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.118.12.1300.json | Frailty Device | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1180.json | Malignant Neoplasms of Lower and Unspecified Limbs | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1181.json | Mechanical Complications Excluding Upper Body | active | | | 2022-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1182.json | Mechanical Complications Excluding Upper Body | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1183.json | Partial Arthroplasty of Hip | active | | | 2022-09 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1184.json | Partial Arthroplasty of Hip | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1188.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2022-12 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1189.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1190.json | Antibiotic Medications for Upper Respiratory Infection | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1193.json | Malignant Neoplasms | active | | | 2022-09 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1194.json | Malignant Neoplasms | active | | | 2022-09 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1196.json | Atherosclerosis of the Extremities | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1197.json | Atherosclerosis of the Extremities | active | | | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1198.json | Atherosclerosis of the Extremities | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1199.json | Lower Extremity Neurological Assessment Result or Finding | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.11.1001.json | Disorders of the Immune System | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.11.1003.json | Disorders of the Immune System | active | | | 2024-02 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.11.1004.json | HIV Viral Load | active | | | 2025-02 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.11.1008.json | HIV 2 | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.11.1010.json | HIV 2 | active | | | 2017-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.11.1011.json | Severe Combined Immunodeficiency | active | | | 2017-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.11.1012.json | Severe Combined Immunodeficiency | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.12.1001.json | Disorders of the Immune System | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.12.1002.json | HIV Viral Load | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.12.1003.json | HIV | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.120.12.1007.json | Severe Combined Immunodeficiency | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1200.json | Lower Extremity Neurological Tests | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1201.json | Lower Extremity Visual Inspection Result or Finding | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1202.json | Lower Extremity Visual Inspection Test | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1203.json | Monofilament Test Result or Finding | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1204.json | Monofilament Tests | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1205.json | Pedal Pulse Result or Finding | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1206.json | Peripheral Neuropathy | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1207.json | Peripheral Neuropathy | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1208.json | Peripheral Neuropathy | active | | | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1209.json | Amputation of Bilateral Feet | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.121.11.1011.json | Consultant Report | active | | | 2022-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.121.11.1028.json | BMI percentile | active | | | 2017-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.121.11.1030.json | Height | active | | | 2019-03 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.121.11.1031.json | Weight | active | | | 2017-05 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.121.12.1006.json | Consultant Report | active | | | 2024-09 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.121.12.1012.json | BMI percentile | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.121.12.1014.json | Height | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.121.12.1015.json | Weight | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1210.json | Amputation of Bilateral Feet | active | | | 2023-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1211.json | Amputation of Bilateral Feet | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1212.json | Amputation of Left Foot | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1213.json | Amputation of Left Foot | active | | | 2023-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1214.json | Amputation of Left Foot | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1215.json | Amputation of Right Foot | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1216.json | Amputation of Right Foot | active | | | 2023-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1217.json | Amputation of Right Foot | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1218.json | Amputation of Unspecified Foot | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1219.json | Amputation of Unspecified Foot | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.122.11.1003.json | Ambulatory | active | | | 2021-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.122.12.1003.json | Ambulatory | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1220.json | Foot Assessment With Abnormal Result or Finding | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1221.json | Foot Assessment With Abnormal Result or Finding | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1222.json | Acquired Absence of Bilateral feet | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1223.json | Acquired Absence of Bilateral feet | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1224.json | Acquired Absence of Left Foot | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1225.json | Acquired Absence of Left Foot | active | | | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1226.json | Acquired Absence of Left Foot | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1227.json | Acquired Absence of Right Foot | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1228.json | Acquired Absence of Right Foot | active | | | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1229.json | Acquired Absence of Right Foot | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1230.json | Lower Body Fractures Excluding Ankle and Foot | active | | | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1231.json | Malignant Neoplasms of Lower and Unspecified Limbs | active | | | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1232.json | Mechanical Complications Excluding Upper Body | active | | | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1233.json | Partial Arthroplasty of Hip | active | | | 2025-01 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1234.json | Partial Arthroplasty of Hip | active | | | 2023-07 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1235.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1236.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2023-07 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1237.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2023-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1238.json | Primary THA Procedure | active | | | 2023-07 | us | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1239.json | Foot Ulcer | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1240.json | Foot Ulcer | active | | | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1241.json | Foot Ulcer | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1242.json | Referral for Foot Care | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1243.json | Therapeutic Footwear | active | | | 2023-08 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1244.json | Foot Deformity | active | | | 2023-07 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1245.json | Foot Deformity | active | | | 2023-07 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1246.json | Foot Deformity | active | | | 2023-07 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1247.json | Megestrol Medications | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1248.json | Meperidine Medications | active | | | 2024-01 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1249.json | Potentially Harmful Antidepressants for Older Adults | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1004.json | Fluoride Varnish Application for Children | active | | | 2024-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1007.json | Dental Caries | active | | | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1009.json | Dental Caries | active | | | 2017-05 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1010.json | Clinical Oral Evaluation | active | | | 2017-05 | us | hl7 | |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1011.json | Fluoride Varnish Application for Children | active | | | 2024-02 | us | hl7 | |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.12.1002.json | Fluoride Varnish Application for Children | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.12.1003.json | Clinical Oral Evaluation | active | | | 2017-05 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.12.1004.json | Dental Caries | active | | | 2021-02 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1250.json | Potentially Harmful Antihistamines for Older Adults | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1251.json | Potentially Harmful Antiparkinsonian Agents for Older Adults | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1252.json | Potentially Harmful Barbiturates for Older Adults | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1253.json | Potentially Harmful Estrogens for Older Adults | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1254.json | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1255.json | Potentially Harmful Pain Medications for Older Adults | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1256.json | Potentially Harmful Skeletal Muscle Relaxants for Older Adults | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1257.json | Potentially Harmful Sulfonylureas for Older Adults | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1258.json | Substance Use Disorder Long Acting Medication | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1259.json | Substance Use Disorder Short Acting Medication | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1260.json | Viloxazine | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1266.json | Diabetic Retinopathy Severity Level | active | | | 2025-01 | us | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1272.json | Diabetes | active | | | 2025-01 | us | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1273.json | Diabetes | active | | | 2025-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.195.11.1003.json | Counseling for Nutrition | active | | | 2017-05 | us | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.195.11.1004.json | Counseling for Nutrition | active | | | 2023-02 | us | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.195.12.1003.json | Counseling for Nutrition | active | | | 2022-03 | us | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1001.json | Antibiotic Medications for Pharyngitis | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1078.json | Nifedipine Medications | active | | | 2022-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1080.json | Contraceptive Medications | active | | | 2025-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1109.json | Meperidine Medications | active | | | 2024-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1129.json | Desiccated Thyroid Medications | active | | | 2021-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1143.json | Isotretinoin | active | | | 2022-01 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1167.json | Dipyridamole Medications | active | | | 2021-02 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1205.json | Leucovorin | active | | | 2023-07 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1211.json | Aspirin and Other Antiplatelets | active | | | 2024-06 | us | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1212.json | DTaP Vaccine | active | | | 2024-11 | us | hl7 | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1214.json | Hepatitis A Vaccine | active | | | 2018-03 | us | hl7 | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1216.json | Hepatitis B Vaccine | active | | | 2025-04 | us | hl7 | cvx |